SHE:002603 Revenue

Shijiazhuang Yiling Pharmaceutical had revenue of 1.83B CNY in the quarter ending September 30, 2025, with 3.78% growth. This brings the company's revenue in the last twelve months to 6.01B, down -25.83% year-over-year. In the year 2024, Shijiazhuang Yiling Pharmaceutical had annual revenue of 6.51B, down -36.88%.

Revenue (ttm)

6.01B

Revenue Growth

-25.83%

P/S Ratio

4.94

Revenue / Employee

513.74K

Employees

11,708

Market Cap

29.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.51B	-3.81B	-36.88%
Dec 31, 2023	10.32B	-2.21B	-17.67%
Jan 1, 2023	12.53B	2.42B	23.88%
Jan 1, 2022	10.12B	1.33B	15.19%
Dec 31, 2020	8.78B	2.96B	50.76%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jan 1, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
WuXi AppTec	43.07B
Yunnan Baiyao Group Co.,Ltd	40.84B
Shanghai Fosun Pharmaceutical (Group)	39.55B
Shenzhen Mindray Bio-Medical Electronics	33.07B
Jiangsu Hengrui Medicine	30.98B
Zhejiang NHU Company	22.47B
Aier Eye Hospital Group	22.17B
Shanghai United Imaging Healthcare	12.20B

Revenue Rankings